joe rogan on semaglutide I was sent this clip with @joerogan and @billmaher talking about obesity as a disease and the new GLP-1 meds (eg wegovy and ozempic). I had to make a few comments because there were some false I was sent this clip

Part 1: diagnostics update 2024

The prescription of GLP-1 RAs in persons with SMI-SUD needs to be informed by the reported safety and tolerability profiles of these agents, with some aspects of relevance to persons with SMI-SUD (Table 1)

10.3389/fimmu.2024.1310443 93 GhasemiN.RazaviS.NikzadE

Musicki, B

Novo Nordisk, que fabrica Ozempic y Wegovy (principio activo: semaglutida), y Eli Lilly, que fabrica Mounjaro y Zepbound (tirzepatida), pasaron por el riguroso proceso de la FDA para obtener la aprobacin regulatoria para estos medicamentos GLP-1, que incluye estudiar su seguridad y eficacia e inspeccionar las instalaciones de fabricacin

Patients who escalate faster than recommended, for any reason, tend to experience more pronounced motility-related side effects, including belching, nausea, and early satiety simultaneously